facebook
Traded Co logo
Submit
Daily limit: 0/10

Michael I. Dollinger, David B. Dollinger & Barrie Dollinger Mengarelli Acquire Industrial Asset In Sunnyvale For $9.2M

Property Image
SOLD
$9,200,000

California

See Similar Deals
Industrial31,000 SF
Sold 03/20/2025
the dealdetailscomps
Property Image
SOLD

Michael I. Dollinger, David B. Dollinger & Barrie Dollinger Mengarelli Acquire Industrial Asset In Sunnyvale For $9.2M

428 Oakmead Parkway

See Similar Deals
Industrial31,000 SF
Sold 03/20/2025
the dealdetailscomps

Summary

CALIFORNIA
Asset Type:Industrial
Price Per Square Foot:$296
Total Square Footage:31,000 SF
Transaction Type:Sale

The property asset involved in this transaction is an industrial space located at 428 Oakmead Parkway in Sunnyvale. The transaction took place on March 20, 2025, with a price of $9,200,000.00 for an area of 31,000 square feet.

Summary of transaction details:

  • Property Type: Industrial
  • Transaction Amount: $9,200,000.00
  • Address: 428 Oakmead Parkway
  • Market: Sunnyvale
  • Buyer: Michael I. Dollinger, David B. Dollinger & Barrie Dollinger Mengarelli - Dollinger Properties
  • Seller: Edward Amento - Molecular Medicine Research Institute

The deal features Michael I. Dollinger, David B. Dollinger, and Barrie Dollinger Mengarelli representing Dollinger Properties as the buyers. Edward Amento represented the Molecular Medicine Research Institute as the seller in this transaction.

Players

DP
Dollinger Properties
BUYER
DP
Dollinger Properties
BUYER
DP
Dollinger Properties
BUYER

Details

SOLD
IMAGE: Michael I. Dollinger, David B. Dollinger, Barrie Dollinger Mengarelli & Edward Amento DATE: 03/20/2025 ADDRESS: 428 Oakmead Parkway MARKET: Sunnyvale ASSET TYPE: Industrial BUYER: Michael I. Dollinger, David B. Dollinger & Barrie Dollinger Mengarelli - Dollinger Properties SELLER: Edward Amento - Molecular Medicine Research Institute SALE PRICE: $9,200,000 SF: 31,000 ~ PPSF: $297 NOTE: Dollinger Properties acquired a 31,000-square-foot R&D building at 428 Oakmead Parkway in Sunnyvale for $9.2 million in a sale-leaseback deal with seller Molecular Medicine Research Institute. The purchase adds to Dollinger’s Bay Area portfolio, following recent acquisitions in Oakland and Fremont.

Stay in the Know

Subscribe for insider commercial real estate news, deal highlights, and market insights—delivered straight to your inbox.

By subscribing, you agree to our Terms of Service and Privacy Policy.

Similar Deals

Suggestions
CRE CalculatorAnalyze deals based on income, expenses, and financing. We automatically filled the calculator with data from the deal you are viewing, fill free to modify it to see how it affects the results.
Deal Type
Operating Income
Operating Expenses (Annual)
Net Operating Income (NOI)

$490,666.68

Debt Service Coverage Ratio (DSCR)

0.94x

Cap Rate

5.33%

Cash Flow (Annual)-$32,685.64
Cash-on-Cash Return-1.27%
Monthly Debt Service$43,612.69
Annual Debt Service$523,352.32